Thu, January 9, 2025
[ Thu, Jan 09th 2025 ]: Kiplinger
The Best Bank ETFs to Buy
Wed, January 8, 2025
[ Wed, Jan 08th 2025 ]: MSN
Could Ethereum Reach $5,000 in 2025?
Tue, January 7, 2025

Moderna Stock Is Volatile Amid Bird Flu Developments

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. tock-is-volatile-amid-bird-flu-developments.html
  Print publication without navigation Published in Stocks and Investing on by Kiplinger
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains editorial commentary or bias from the source
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
The article from Kiplinger discusses the volatile nature of Moderna's (MRNA) stock due to recent developments concerning bird flu. Moderna's stock experienced significant fluctuations after the company announced it was developing an mRNA-based vaccine for the H5N1 bird flu virus, which has been detected in U.S. dairy cows, raising concerns about potential human transmission. The stock initially surged on this news but later saw declines amid broader market concerns and uncertainties about the vaccine's development timeline and efficacy. The article highlights the speculative nature of investing in biotech stocks like Moderna, where news about potential pandemics or vaccine developments can lead to rapid stock price changes. Additionally, it notes that while Moderna has been successful with its COVID-19 vaccine, the path to market for new vaccines can be fraught with challenges, including regulatory hurdles and competition from other pharmaceutical companies.

Read the Full Kiplinger Article at:
[ https://www.kiplinger.com/investing/stocks/moderna-mrna-stock-is-volatile-amid-bird-flu-developments ]